New data show patients with chronic low back pain maintained pain reduction on duloxetine
- Details
- Category: Boehringer Ingelheim
New data show patients with chronic low back pain on duloxetine hydrochloride (Cymbalta®) maintained reductions in pain for 41 weeks.(1) In patients who initially responded to duloxetine, this maintenance of pain reduction was accompanied by further reduction in pain that was statistically significant as measured by the Brief Pain Inventory (BPI) average pain rating.(1)
Abbott to Acquire Evalve, Inc., a Leader in Minimally Invasive Cardiac Valve Repair Technology
- Details
- Category: Abbott
Abbott (NYSE: ABT) has announced a definitive agreement to acquire the outstanding equity of Evalve, Inc., the global leader in the development of devices for minimally invasive repair of cardiac mitral valves. The acquisition provides Abbott with a presence in the growing area of non-surgical treatment for structural heart disease, in which physicians use catheter-based devices to repair or replace basic structural components of the heart such as mitral and aortic valves.
FDA Advisory Committee makes favorable recommendation for Cervarix
- Details
- Category: GlaxoSmithKline
GlaxoSmithKline (NYSE: GSK) has announced that the U.S. Food and Drug Administration's (FDA) Vaccines and Related Biological Products Advisory Committee (VRBPAC) voted that clinical data support both the efficacy and safety of CERVARIX®, the company's candidate cervical cancer vaccine (12-1 and 11-1, respectively).
Online Video Library Launched To Share Martha Beck's Experience Living with Fibromyalgia
- Details
- Category: Eli Lilly and Company
For people living with painful conditions, September is a time for their true stories of triumph to emerge. Helping to foster support and communication, National Pain Awareness Month allows people with painful conditions to educate others about their experiences, build connections and together fight their pain.
Abbott Again Named One of the 'Best Places to Launch a Career' by BusinessWeek
- Details
- Category: Abbott
For the fourth consecutive year, Abbott (NYSE: ABT) has been named one of the "50 Best Places to Launch a Career" by BusinessWeek magazine. The list highlights companies that excel at offering a superior workplace for entry-level employees. This year, Abbott moved up to No. 13, and was once again the top-ranked health care company on the list.
Shantha Biotechnics Awarded Large Vaccine Contracts by United Nations Agency
- Details
- Category: Sanofi
Sanofi Pasteur, the vaccines division of sanofi-aventis Group (EURONEXT : SAN and NYSE : SNY), announced that Shantha Biotechnics was awarded contracts by a United Nations agency for supplies of pentavalent vaccine SHAN5™ (combination vaccine of Diphtheria, Pertussis, Tetanus, Haemophilus influenza B, and Hepatitis B). The contracts, worth $340 million, cover the period 2010-2012.
Roche recognised as new Super Sector Leader in Dow Jones Sustainability Index
- Details
- Category: Roche
Roche (SIX: RO, ROG; OTCQX: RHHBY) has been rated as the new Super Sector Leader in Healthcare on the Dow Jones Sustainability Index, placing Roche as the most sustainable healthcare company worldwide.
More Pharma News ...
- Novartis MF59® vaccine shows strong immune response in A(H1N1) clinical trials
- Abbott to Acquire Visiogen, Expanding Vision Care Portfolio
- Bayer Acquires Two Prescription Dermatology Product Lines from SkinMedica in the U.S.
- Pfizer Concludes Previously Disclosed Settlement Agreement with U.S. Department of Justice
- New Analysis of the Pfizer-Sponsored TNT Clinical Trial
- Abbott Launches Next-Generation XIENCE PRIME(TM) Drug Eluting Stent in International Markets
- Phase III Head to Head Trial Showed Ticagrelor Reduced Cardiovascular Death and Heart Attacks